Sal Daher - Lessons Learned - PODCAST LAUNCH DELAYED UNTIL 12/29/23 at 1:30 AM - Apologies!!
00:02:2312/27/2023
Tom Weldon - A Fountain of Youth
00:45:4712/20/2023
Sal Daher - Startups in the IRA? Pros & Cons from Decades of Investing
00:12:5912/13/2023
Paul Hartung - Fund a Biotech Startup in Hard Times
00:09:3012/13/2023
Raul Rosa - Art and Craft
00:35:5412/13/2023
Katharine Woodman-Maynard - Talent and Wisdom
00:46:2012/6/2023
Ethan Pierce - AI Helps Kids Read
00:35:3111/29/2023
Brian Denenberg - Helping Startups Grow
00:41:4911/22/2023
Brian Freeman, MD - Burn More Calories
00:44:0011/15/2023
Angel Invest Boston
In the Decade of Biotech when there will be myriad opportunities to invest in angel-scale biotech startups. After decades of angel investing, I am focusing on the life science side of my portfolio and invite other angels to do the same. Here's why: https://www.labcoatventures.com/why-we-are-focused-on-early-stage-biotech/
I’m Sal Daher, host of the Angel Invest Boston Podcast. After immigrating to Boston as a child and attending Belmont High School, I studied engineering at MIT and Stanford. Decades of work in international finance followed. During that time, I invested in a handful of ventures founded by friends and acquaintances. Now, I’m a member of Walnut Ventures and MIT Angels and spend most of my time as an angel investor. Startups in my portfolio include: SQZ Biotech, Gelesis, Akili Interactive, Vedanta Biosciences, FineTune Learning, Concrete Sensors, Squadle, doDoc, Pixability, Mavrck, Viral Gains, Streamroot, XMOS, Alice's Table and others. Exits include: Exos (Microsoft), Rifiniti (KKR) and PIKA Energy (Generac).